Multidisciplinary planning with prophylactic REBOA in cesarean delivery for a giant uterine leiomyoma: a case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262133Keywords:
Uterine leiomyoma, REBOA, Obstetric hemorrhage, PregnancyAbstract
Large uterine leiomyomas during pregnancy may significantly influence the mode of delivery, hinder access to the uterine cavity and increase the risk of hemorrhage during cesarean delivery. Evidence regarding prophylactic aortic balloon occlusion (REBOA) in this context is limited. A 25-year-old primigravid woman with gestational diabetes, preeclampsia and early-onset fetal growth restriction was found to have a previously undiagnosed giant uterine leiomyoma measuring 17×14×13 cm on magnetic resonance imaging. Due to its size and location, a cesarean delivery was planned at 34+2 weeks with prophylactic REBOA placement. Blood loss was within the expected range and balloon inflation was not required. Maternal and neonatal outcomes were favourable. Prophylactic REBOA may be considered in selected high-risk cesarean deliveries.
References
Dayanan R, Duygulu BD, Ayas OM, Karabay G, Seyhanli Z, Beydilli SE, et al. Influence of uterine fibroid size on perinatal and neonatal outcomes: a single-centre cohort of 651 pregnancies. BMC Pediatr. 2025;25:750.
Ramasauskaite D, Purandare N, Diaz I, Kvederaite-Budre G, Beyuo TK, Beyeza-Kashesya J, et al. Fibroids and pregnancy. Int J Gynecol Obstet. 2026;172(1):51-8.
Li H, Hu Z, Fan Y, Hao Y. The influence of uterine fibroids on adverse outcomes in pregnant women: a meta-analysis. BMC Pregnancy Childbirth. 2024;24:345.
Huang Y, Ming X, Li Z. Feasibility and safety of performing cesarean myomectomy: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2022;35(13):2619-27.
Brennan LC, Gauthier R, Kumbhar S, Magann EF, Owen J, Cunningham FG. Cesarean myomectomy for large uterine fibroids: surgical outcomes from a single-center case series. Int J Gynecol Obstet. 2026;172(2):1198-201.
Ordoñez CA, Manzano-Nunez R, Parra MW, Rasmussen TE, Nieto AJ, Herrera-Escobar JP, et al. Prophylactic use of resuscitative endovascular balloon occlusion of the aorta in women with abnormal placentation: a systematic review, meta-analysis, and case series. J Trauma Acute Care Surg. 2018;84(5):809-18.
Chen D, Xu J, Tian Y, Ling Q, Peng B. Clinical evaluation of the effect for prophylactic balloon occlusion in pregnancies complicated with placenta accreta spectrum disorder. Int J Gynecol Obstet. 2024;167(1):109-27.
Kluck SL, Morrison JJ, Torkington J, Pacheco LD, Fox KA, McCarthy RJ, et al. Aortic balloon occlusion in distal zone 3 reduces blood loss from obstetric hemorrhage in placenta accreta spectrum. J Trauma Acute Care Surg. 2023;94(5):710-7.
Kamijo K, Matsumoto H, Hara Y, Saito N, Takahashi M, Yamamoto S, et al. Resuscitative endovascular balloon occlusion of the aorta for life-threatening postpartum hemorrhage: a nationwide observational study in Japan. J Trauma Acute Care Surg. 2022;93(3):418-23.
Webster LA, Peschmann JR, Duong T, Johnson JO, Smith MP, Sato M, et al. REBOA: expanding applications from traumatic hemorrhage to obstetrics and cardiopulmonary resuscitation, from the AJR Special Series on Emergency Radiology. AJR Am J Roentgenol. 2023;220(1):16-22.
Theodorou CM, Rinderknecht TN, Girda E, Galante JM, Russo RM. Fetal and neonatal outcomes following maternal aortic balloon occlusion for hemorrhage in pregnancy: a review of the literature. J Trauma Acute Care Surg. 2022;92(1):10-7.
Downloads
Published
How to Cite
Issue
Section
